Ken Fisher's KNSA Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 428,972 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $20.66 M, representing 0.01% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 8 quarters.
Based on 13F filings, Ken Fisher has maintained this position in KNSA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 180,029 shares. Largest reduction occurred in Q2 2025, reducing 41,992 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +161,698 | Add 60.50% | 428,972 | $48.15 |
| Q4 2025 | -15,014 | Reduce 5.32% | 267,274 | $41.25 |
| Q3 2025 | +180,029 | Add 176.05% | 282,288 | $38.83 |
| Q2 2025 | -41,992 | Reduce 29.11% | 102,259 | $27.67 |
| Q1 2025 | +118,127 | Add 452.18% | 144,251 | $22.21 |
| Q3 2024 | -4,101 | Reduce 13.57% | 26,124 | $24.99 |
| Q2 2024 | +30,225 | New Buy | 30,225 | $18.67 |
Ken Fisher's Kiniksa Pharmaceuticals International plc Investment FAQs
Ken Fisher first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q2 2024, acquiring 30,225 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Kiniksa Pharmaceuticals International, plc (KNSA) for 8 quarters since Q2 2024.
Ken Fisher's largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q3 2025, adding 282,288 shares worth $10.96 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 428,972 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $20.66 M.
As of the Q1 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 428,972 shares, as reported at the end of Q1 2026.